The Cigna Group (NYSE:CI) Stock Position Lowered by Mn Services Vermogensbeheer B.V.

Mn Services Vermogensbeheer B.V. lessened its position in The Cigna Group (NYSE:CI) by 1.2% in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 114,300 shares of the health services provider’s stock after selling 1,400 shares during the quarter. Mn Services Vermogensbeheer B.V.’s holdings in The Cigna Group were worth $39,598,000 as of its most recent filing with the SEC.

Several other hedge funds have also made changes to their positions in the company. Norden Group LLC lifted its position in The Cigna Group by 22.3% in the 1st quarter. Norden Group LLC now owns 2,355 shares of the health services provider’s stock worth $855,000 after buying an additional 429 shares in the last quarter. Janney Montgomery Scott LLC lifted its position in The Cigna Group by 3.6% in the 1st quarter. Janney Montgomery Scott LLC now owns 30,151 shares of the health services provider’s stock worth $10,951,000 after buying an additional 1,037 shares in the last quarter. Choreo LLC lifted its position in The Cigna Group by 54.6% in the 1st quarter. Choreo LLC now owns 1,623 shares of the health services provider’s stock worth $590,000 after buying an additional 573 shares in the last quarter. Financial Counselors Inc. lifted its position in The Cigna Group by 2.2% in the 1st quarter. Financial Counselors Inc. now owns 1,748 shares of the health services provider’s stock worth $635,000 after buying an additional 38 shares in the last quarter. Finally, Rehmann Capital Advisory Group purchased a new stake in The Cigna Group in the 1st quarter worth approximately $268,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Insider Transactions at The Cigna Group

In other news, Director William J. Delaney III sold 2,691 shares of the firm’s stock in a transaction dated Monday, August 19th. The shares were sold at an average price of $342.68, for a total transaction of $922,151.88. Following the completion of the transaction, the director now directly owns 17,539 shares of the company’s stock, valued at approximately $6,010,264.52. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.60% of the stock is owned by insiders.

Analysts Set New Price Targets

CI has been the subject of a number of research analyst reports. JPMorgan Chase & Co. increased their target price on shares of The Cigna Group from $435.00 to $438.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 21st. Cantor Fitzgerald restated an “overweight” rating and set a $400.00 price target on shares of The Cigna Group in a research note on Wednesday, October 23rd. Barclays increased their price target on shares of The Cigna Group from $393.00 to $405.00 and gave the stock an “overweight” rating in a research note on Friday, August 2nd. Jefferies Financial Group increased their price target on shares of The Cigna Group from $402.00 to $422.00 and gave the stock a “buy” rating in a research note on Tuesday, September 17th. Finally, StockNews.com upgraded shares of The Cigna Group from a “buy” rating to a “strong-buy” rating in a research note on Friday, August 2nd. One investment analyst has rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of $392.29.

The Cigna Group Stock Performance

NYSE CI traded down $0.62 during midday trading on Monday, hitting $315.87. The company had a trading volume of 286,617 shares, compared to its average volume of 1,520,881. The company has a quick ratio of 0.71, a current ratio of 0.72 and a debt-to-equity ratio of 0.71. The stock has a market cap of $88.30 billion, a price-to-earnings ratio of 29.86, a P/E/G ratio of 0.95 and a beta of 0.51. The firm has a fifty day simple moving average of $345.77 and a two-hundred day simple moving average of $341.48. The Cigna Group has a fifty-two week low of $253.95 and a fifty-two week high of $370.83.

The Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, October 31st. The health services provider reported $7.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.22 by $0.29. The company had revenue of $63.70 billion for the quarter, compared to analyst estimates of $59.58 billion. The Cigna Group had a net margin of 1.31% and a return on equity of 18.42%. The business’s quarterly revenue was up 29.8% on a year-over-year basis. During the same period last year, the business posted $6.77 EPS. Equities analysts forecast that The Cigna Group will post 28.48 earnings per share for the current fiscal year.

The Cigna Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 19th. Stockholders of record on Wednesday, December 4th will be issued a dividend of $1.40 per share. This represents a $5.60 dividend on an annualized basis and a dividend yield of 1.77%. The ex-dividend date of this dividend is Wednesday, December 4th. The Cigna Group’s payout ratio is 52.83%.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.